UniProt ID | Protein Name | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology |
---|---|---|---|---|---|
A0A7J8HNY1 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A7J8GFA5 | Proto-oncogene tyrosine-protein kinase receptor Ret |
|
1 | 0 |
|
A0A7J8H4M8 | P2X purinoceptor |
|
1 | 0 |
|
A0A7J8EI11 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A7J8D7N0 | Paraoxonase |
|
2 | 0 |
|
A0A7J8HUJ9 | Phosphoinositide phospholipase C |
|
2 | 0 |
|
A0A7J8GVN6 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
A0A7J8F2V9 | Peptidylglycine alpha-amidating monooxygenase |
|
1 | 0 |
|
A0A7J8HN92 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A7J8E916 | N-acylethanolamine-hydrolyzing acid amidase |
|
4 | 0 |
|
A0A7J8G4Y9 | Angiotensin-converting enzyme |
|
5 | 0 |
|
A0A7J8EIG0 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A7J8BQ35 | Voltage-dependent P/Q-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A7J8GDC7 | Noggin |
|
1 | 0 |
|
A0A7J8H3J5 | P2X purinoceptor |
|
1 | 0 |
|
A0A7J8D8H4 | Hyaluronidase |
|
1 | 0 |
|
A0A7J8HLT0 | ADAM metallopeptidase with thrombospondin type 1 motif 5 |
|
2 | 0 |
|
A0A7J8D7S3 | Paraoxonase |
|
2 | 0 |
|
A0A7J8JJK1 | Pannexin 2 |
|
1 | 0 |
|
A0A7J8GWT7 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
A0A7J8GZY0 | Potassium channel subfamily K member |
|
1 | 0 |
|
A0A7J8B8P4 | Voltage-dependent L-type calcium channel subunit alpha |
|
2 | 0 |
|
A0A7J8HM32 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A7J8G7X5 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A7J8GF07 | Proto-oncogene tyrosine-protein kinase receptor Ret |
|
1 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024